News for 2003
The Canadian Agency for Drugs and Technologies in Health (CADTH) is an independent agency funded by Canadian federal, provincial, and territorial governments to provide health care decision makers with credible, impartial advice and information about the effectiveness and efficiency of drugs and other health technologies. Unlike regulators who determine which technologies can be used in Canada, CADTH supports decision makers who are exploring what technologies should be used to achieve the best outcomes both on patient health and the health care system.
For details on how to contact CADTH, visit our Contact Us page.
Teletriage programs tend to reduce emergency room visits
December 15, 2003
OTTAWA — Based on a survey of Canadian teletriage centres, or nursing call centres, four provinces showed a trend to reducing the number of non-urgent visits to emergency rooms. In ...
Spinal Manipulation for Infantile Colic
December 15, 2003
OTTAWA — “There is no convincing evidence that spinal manipulation alone affects the duration of infant colic,” said Don Husereau, lead author of a recent systematic review by the ...
New web site for paediatric health economic research
December 05, 2003
OTTAWA — The Hospital for Sick Children Research Institute has launched a new web site containing detailed citations from more than 1,000 published paediatric economic evaluations. The ...
Genetic testing beneficial for limited number of cancer disorders
December 01, 2003
OTTAWA — The use of genetic tests to identify individuals with a genetic susceptibility to develop cancer is unjustified in the clinical management of many hereditary cancer predisposing ...
Liquid-based cytology and human papillomavirus testing in cervical cancer screening
November 17, 2003
Ottawa — The Canadian Coordinating Office for Health Technology Assessment (CCOHTA) has released a report assessing alternatives to the Pap smear for cervical screening.The two techniques ...
Role of APAP devices in the management of obstructive sleep apnea not established
October 06, 2003
OTTAWA — Auto-titrating nasal continuous positive airway pressure (APAP) devices show promise in the management of obstructive sleep apnea (OSA), but their place in therapy has yet to be ...
Riluzole in the treatment of ALS
September 11, 2003
OTTAWA — Riluzole, the only drug approved in Canada for the treatment of amyotrophic lateral sclerosis (ALS), has the potential to reduce serious morbidity in some ALS patients but may ...
CDR Releases CEDAC Nominations
August 06, 2003
OTTAWA — The federal, provincial and territorial Ministers of Health have announced the membership of the Canadian Expert Drug Advisory Committee (CEDAC), a key component of the new Common ...
CCOHTA to hold workshop on CDR submission requirements
May 30, 2003
OTTAWA — The CDR Directorate of the Canadian Coordinating Office for Health Technology Assessment will hold a free workshop for pharmaceutical manufacturers on Preparing Submissions for the ...
The Canadian Expert Drug Advisory Committee (CEDAC) Nominating Committee will accept nominations of prospective CEDAC members until May 5, 2003
April 07, 2003
OTTAWA - The Canadian Expert Drug Advisory Committee (CEDAC) Nominating Committee will accept nominations of prospective CEDAC members until May 5, 2003. CEDAC is a new independent national ...
Novel Antipsychotics for Dementia-Associated Agitation
March 31, 2003
OTTAWA - The Canadian Coordinating Office for Health Technology Assessment (CCOHTA) released a technology report today on the use of novel antipsychotic drugs for the treatment of ...
Stroke units improve survival and independence for stroke survivors
March 27, 2003
OTTAWA - Stroke patients who receive care in a stroke unit have a better survival rate and are more likely to be independent and living at home after a stroke, concludes a report released today ...
Exercise-Based Cardiac Rehabilitation Programs Show Reductions in Cardiac Mortality
March 13, 2003
OTTAWA - Cardiac rehabilitation programs that include exercise have beneficial effects on cardiac mortality, a report released today by the Canadian Coordinating Office for Health Technology ...
The Canadian Coordinating Office for Health Technology Assessment (CCOHTA) is moving to larger offices to accommodate recent growth
March 05, 2003
CCOHTA IS MOVING! Effective Monday, March 24, 2003, our new address will be:865 Carling Avenue, Suite 600 Ottawa, ON K1S 5S8Our phone number and extensions, fax number, email addresses and ...
Federal Government Invests $45 million in Health Technology Assessment
February 19, 2003
OTTAWA - The Canadian Coordinating Office for Health Technology Assessment enthusiastically welcomes new federal funding of $45 million over 5 years for health technology assessment (HTA) ...